Price
$0.60
Decreased by -2.73%
Dollar volume (20D)
778.61 K
ADR%
37.02
Earnings report date
Oct 14, 2024
Shares float
42.02 M
Shares short
3.41 K [0.01%]
Shares outstanding
43.42 M
Market cap
26.61 M
Beta
-0.39
Price/earnings
N/A
20D range
0.46 2.67
50D range
0.46 2.67

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China.

It operates in two segments, Network and Hospital.

The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners.

In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel.

Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment.

Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services.

Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Mar 26, 24 0.00
Decreased by N/A%
-
Nov 16, 23 0.00
Decreased by N/A%
-
Sep 22, 23 0.00
Decreased by N/A%
-
May 23, 23 0.00
Decreased by N/A%
-
Mar 28, 23 0.00
Decreased by N/A%
-
Nov 17, 22 0.00
Decreased by N/A%
-
Sep 23, 22 0.00
Decreased by N/A%
-
May 24, 22 0.00
Increased by +100.00%
-
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 23 41.05 M
Decreased by -71.55%
-13.13 M
Increased by +88.55%
Decreased by -31.98%
Increased by +59.76%
Mar 31, 23 46.95 M
Decreased by -77.02%
-53.70 M
Increased by +38.15%
Decreased by -114.39%
Decreased by -169.11%
Dec 31, 22 N/A
Decreased by -100.00%
N/A
Increased by +100.00%
- -
Sep 30, 22 N/A
Increased by +100.00%
N/A
Decreased by -100.00%
- -
Jun 30, 22 144.26 M
Decreased by -25.21%
-114.65 M
Decreased by -26.93%
Decreased by -79.47%
Decreased by -69.71%
Mar 31, 22 204.26 M
Increased by +N/A%
-86.83 M
Decreased by N/A%
Decreased by -42.51%
-
Dec 31, 21 292.75 M
Increased by +109.10%
-181.10 M
Increased by +0.05%
Decreased by -61.86%
Increased by +52.20%
Sep 30, 21 -90.48 M
Decreased by N/A%
176.55 M
Increased by +N/A%
Decreased by -195.13%
-
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY